Oncological results of extended resection for locally advanced rectal cancer: the value of postirradiation MRI in predicting local recurrence

Aim The primary purpose of this study was to analyse the overall survival and local recurrence rate after extended resection of locally advanced rectal cancer. The second aim was to determine the ability of the response to radiological irradiation to predict R0 resection. Method A retrospective stud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Colorectal disease 2017-04, Vol.19 (4), p.339-348
Hauptverfasser: Räsänen, M., Ristimäki, A., Savolainen, R., Renkonen‐Sinisalo, L., Lepistö, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim The primary purpose of this study was to analyse the overall survival and local recurrence rate after extended resection of locally advanced rectal cancer. The second aim was to determine the ability of the response to radiological irradiation to predict R0 resection. Method A retrospective study was performed of 94 consecutive patients with locally advanced rectal cancer operated on at the Helsinki University Hospital, Helsinki, Finland between 2005 and 2013. Data were collected from patient records. All patients were treated with an en bloc resection. Sixty‐two patients received preoperative long‐term chemoradiotherapy. Results The 30‐day mortality was 3.2%. Local recurrence occurred in 10 (10.6%) patients. The cumulative 1‐, 3‐ and 5‐year overall survival to each year was 89.4%, 68.3% and 51.8%. The most important prognostic factor for both local recurrence (P = 0.006) and survival (P = 0.003) was an R0 resection. A poor or no response seen on posttreatment MRI predicted local recurrence (P = 0.045) and decreased disease‐free survival in patients treated curatively (P = 0.052). The histological tumour regression grade was not associated with local recurrence or survival. Conclusion Multivisceral resection offers a 5‐year survival of over 50% and local control of advanced rectal cancer in nearly 90% of carefully selected patients.
ISSN:1462-8910
1463-1318
DOI:10.1111/codi.13513